[go: up one dir, main page]

NO984878L - Preparation and Use as Medicines of 3-Alkoxypyridine-2-Carboxylic Acid Amesters - Google Patents

Preparation and Use as Medicines of 3-Alkoxypyridine-2-Carboxylic Acid Amesters

Info

Publication number
NO984878L
NO984878L NO984878A NO984878A NO984878L NO 984878 L NO984878 L NO 984878L NO 984878 A NO984878 A NO 984878A NO 984878 A NO984878 A NO 984878A NO 984878 L NO984878 L NO 984878L
Authority
NO
Norway
Prior art keywords
alkoxypyridine
carboxylic acid
amesters
medicines
preparation
Prior art date
Application number
NO984878A
Other languages
Norwegian (no)
Other versions
NO984878D0 (en
Inventor
Klaus Weidmann
Karl-Heinz Baringhaus
Georg Tschank
Martin Bickel
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO984878D0 publication Critical patent/NO984878D0/en
Publication of NO984878L publication Critical patent/NO984878L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Det blir beskrevet 3-alkoksypyridin-2-karboksylsyreamidestere med formel (I), der R1, R2 og R3 betyr hydrogen, R4 betyr (Cj-C^-alkyl, A betyr en -CH2-gruppe, og et hydro- genatom kan bli erstattet med en metylgruppe, og B betyr -CO2G, hvori G betyr resten av en alkohol GOH, innbefattet fysiologisk virksomme salter; deres fremstilling, anven- delse for hemming av kollagenbiosyntese og deres anvendelse som legemiddel for be- handling av fibrotiske sykdommer.There are disclosed 3-alkoxypyridine-2-carboxylic acid amides of formula (I) wherein R 1, R 2 and R 3 are hydrogen, R 4 is (C 1 -C substituted by a methyl group, and B means -CO2G, wherein G means the residue of an alcohol GOH, including physiologically active salts;

NO984878A 1996-04-30 1998-10-19 Preparation and Use as Medicines of 3-Alkoxypyridine-2-Carboxylic Acid Amesters NO984878L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1996/001793 WO1997041103A1 (en) 1996-04-30 1996-04-30 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and their use as drugs

Publications (2)

Publication Number Publication Date
NO984878D0 NO984878D0 (en) 1998-10-19
NO984878L true NO984878L (en) 1998-12-29

Family

ID=8166212

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984878A NO984878L (en) 1996-04-30 1998-10-19 Preparation and Use as Medicines of 3-Alkoxypyridine-2-Carboxylic Acid Amesters

Country Status (7)

Country Link
EP (1) EP0900202A1 (en)
JP (1) JP2000509047A (en)
KR (1) KR20000065090A (en)
AU (1) AU5762896A (en)
CA (1) CA2253282A1 (en)
NO (1) NO984878L (en)
WO (1) WO1997041103A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2803592A1 (en) * 2000-01-06 2001-07-13 Aventis Cropscience Sa NOVEL DERIVATIVES OF 3-HYDROXYPICOLINIC ACID, PROCESS FOR THEIR PREPARATION AND FUNGICIDAL COMPOSITIONS CONTAINING SAME
AU2002241154A1 (en) 2001-03-21 2002-10-03 Isis Innovation Ltd. Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase
CN102552261A (en) * 2001-12-06 2012-07-11 法布罗根股份有限公司 Methods of increasing endogenous erythropoietin EPO
US7588924B2 (en) 2006-03-07 2009-09-15 Procter & Gamble Company Crystal of hypoxia inducible factor 1 alpha prolyl hydroxylase
PT3357911T (en) 2006-06-26 2022-07-11 Akebia Therapeutics Inc Prolyl hydroxylase inhibitors and methods of use
BR112012010766A2 (en) 2009-11-06 2015-10-06 Aerpio Therapeutics Inc compositions and methods of treating colitis and other intestinal diseases
NO2686520T3 (en) 2011-06-06 2018-03-17
WO2012170442A1 (en) 2011-06-06 2012-12-13 Akebia Therapeutics Inc. Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
PL2938191T3 (en) 2012-12-28 2018-07-31 Dow Agrosciences Llc Synergistic fungicidal mixtures for fungal control in cereals
EP3007695B1 (en) 2013-06-13 2024-02-07 Akebia Therapeutics, Inc. Compositions and methods for treating anemia
CR20160222U (en) 2013-11-15 2016-08-26 Akebia Therapeutics Inc SOLID FORMS OF ACID {[- (3- CHLOROPHENYL) -3- HYDROXIPIRIDIN -2-CARBONIL] AMINO} ACETIC, COMPOSITIONS, AND USES OF THE SAME
US10188109B2 (en) 2014-12-30 2019-01-29 Dow Agrosciences Llc Picolinamide compounds with fungicidal activity
BR112017013589A2 (en) * 2014-12-30 2018-03-06 Dow Agrosciences Llc picolinamides with fungicidal activity
MX2017008422A (en) 2014-12-30 2017-10-02 Dow Agrosciences Llc PICOLINAMIDE COMPOUNDS WITH FUNGICIDE ACTIVITY.
KR20170100620A (en) 2014-12-30 2017-09-04 다우 아그로사이언시즈 엘엘씨 Uses of picolinamide as fungicide
CN107426999B (en) 2014-12-30 2023-01-20 美国陶氏益农公司 Pyridine amide compounds having fungicidal activity
CA2974691A1 (en) 2015-01-23 2016-07-28 Akebia Therapeutics, Inc. Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof
UA123308C2 (en) 2015-04-01 2021-03-17 Екебіа Терапьютікс, Інк. COMPOSITIONS AND METHODS FOR TREATMENT OF ANEMIA
US20180243271A1 (en) * 2015-05-28 2018-08-30 Japan Tobacco Inc. Method for Treating or Preventing Diabetic Nephropathy
TWI774761B (en) 2017-05-02 2022-08-21 美商科迪華農業科技有限責任公司 Synergistic mixtures for fungal control in cereals
CN110996665B (en) 2017-05-02 2021-10-26 陶氏益农公司 Use of acyclic picolinamides as fungicides against fungal diseases on turfgrass
TW201842851A (en) 2017-05-02 2018-12-16 美商陶氏農業科學公司 Synergistic mixture for fungal control in cereals
BR102019004480B1 (en) 2018-03-08 2023-03-28 Dow Agrosciences Llc PICOLINAMIDES AS FUNGICIDES
JP7440989B2 (en) 2018-05-09 2024-02-29 アケビア セラピューティクス インコーポレイテッド Method for preparing 2-[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid
CA3115684A1 (en) 2018-10-15 2020-04-23 Dow Agrosciences Llc Methods for sythesis of oxypicolinamides
CN114554848A (en) 2019-10-18 2022-05-27 科迪华农业科技有限责任公司 Process for the synthesis of picolinamides
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0650960T3 (en) * 1993-11-02 1997-09-01 Hoechst Ag Substituted heterocyclic carboxylic acid amide esters, their preparation and their use as drugs.

Also Published As

Publication number Publication date
EP0900202A1 (en) 1999-03-10
KR20000065090A (en) 2000-11-06
WO1997041103A1 (en) 1997-11-06
JP2000509047A (en) 2000-07-18
AU5762896A (en) 1997-11-19
NO984878D0 (en) 1998-10-19
CA2253282A1 (en) 1997-11-06

Similar Documents

Publication Publication Date Title
NO984878L (en) Preparation and Use as Medicines of 3-Alkoxypyridine-2-Carboxylic Acid Amesters
NO963053L (en) Cosmetic or pharmaceutical preparations containing mangiferin or derivatives thereof
DE69930926D1 (en) BENZOLSULFONAMIDE DERIVATIVES AND THEIR USE AS MEDICAMENTS
MY102866A (en) Amide derivatives.
NO20101069L (en) Use of certain NMDA affinity antagonists as antidepressants
DE69939532D1 (en) GAMMA AMINOBUTTERIC ACID DERIVATIVES, SOLID MEDICAMENTS AND METHOD FOR THE PRODUCTION THEREOF
NO904839L (en) PROCEDURE FOR PREPARING BENZOXAZINE DERIVATIVES.
ES2124545T3 (en) AZOLIDINDIONAS AS ANTI-HYPERGLYCEMIC AGENTS.
ATE233724T1 (en) CYCLOHEXENONE LONG CHAIN ALCOHOL AND MEDICINAL PRODUCTS CONTAINING SAME
DE69401584D1 (en) BETA, BETA-DIMETHYL-4-PIPERIDINETHANAMINE DERIVATIVES AS INHIBITORS OF THE CHOLESTERIN BIOSYNTHESIS
NZ309151A (en) a 3-substituted cyano or carbamoyl pyrrole derivative and pharmaceutical composition
UA41928C2 (en) OXAZOLIDINE DERIVATIVES, METHOD OF OBTAINING THEM, PHARMACEUTICAL COMPOSITION AND METHOD OF ITS OBTAINING, METHOD OF TREATMENT OF DISEASES
HUP9801881A2 (en) Hydroximic acid derivatives, preparation and use thereof, pesticide and fungicide compositions containing these compounds as active ingredients
DE69512208D1 (en) AMINO ACID DERIVATIVES AND THEIR USE AS PHOSPHOLIPASE-A2 INHIBITORS
NO913391L (en) PROCEDURE FOR THE PREPARATION OF NEW HETRAZEPINOID ACIDAMIDS.
CA2202904A1 (en) Pharmaceutical composition for prophylaxis and treatment of type i allergic diseases
ATE48994T1 (en) BENZIMIDAZOLE DERIVATIVE, PROCESS FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION.
NO20006350L (en) Derivatives of 3- (2-oxo- [1,3 '] bipyrrolidinyl-3-ylidene methyl) cephemer
YU6996A (en) USE OF BENZOTHOPHENE TO OBTAIN MEDICINE
NO20043286L (en) Piperidine derivative compounds and drugs containing the compounds as the active ingredient
ATE344237T1 (en) HYDROXYACETAMIDOBENZENESULFONAMIDE DERIVATIVES
NO985974L (en) Piperidinedacetic acid derivatives and their use in the treatment of thrombosis diseases
AU658175B2 (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
DE69414396D1 (en) ACYLPHENYLGLYCIN DERIVATIVE AND THIS PREVENTIVE AND HEALING AGENT CONTAINING ACTIVE SUBSTANCES AGAINST DISEASES CAUSED BY INCREASED COLLAGENASE ACTIVITY
DE69615657D1 (en) ANTIFUNGAL FUSACANDINE

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application